**Core Concept**
Migraine treatment involves various pharmacological and non-pharmacological strategies aimed at aborting the attack or preventing future episodes. These approaches target the complex pathophysiology of migraine, which involves neuronal activation, vasodilation, and inflammation.

**Why the Correct Answer is Right**
The correct answer is not provided, but based on common migraine treatment options, we can discuss the typical management strategies. Most patients are initially treated with triptans, which are selective serotonin receptor agonists that bind to 5-HT1B/1D receptors, causing vasoconstriction and inhibition of pro-inflammatory neuropeptide release. Other options include ergotamines, which have a similar mechanism of action, and NSAIDs, which may be used for mild to moderate attacks.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect, as triptans are the first-line treatment for acute migraine attacks, especially for those with moderate to severe symptoms.
**Option B:** Incorrect, as ergotamines are also used to treat migraine, particularly for patients who do not respond to triptans or have contraindications to them.
**Option C:** Incorrect, as NSAIDs are indeed used for treating migraine, especially for mild to moderate attacks.
**Option D:** This option is not provided, but it's assumed to be the incorrect answer.

**Clinical Pearl / High-Yield Fact**
A key aspect of migraine treatment is the use of abortive medications, which should be initiated as soon as possible after the onset of symptoms to maximize efficacy. The "4-hour window" rule suggests that treatments are most effective when started within 4 hours of migraine onset.

**Correct Answer:** Not Provided